Brief: Freeline Presents Long-Term Follow-Up Data From Phase 1/2 B-AMAZE Trial In Hemophilia B

Freeline Therapeutics Holdings

13/12/2021 14:50

Dec 13 (Reuters) - Freeline Therapeutics Holdings PLC  FRLN.O :
    * FREELINE PRESENTS LONG-TERM FOLLOW-UP DATA FROM PHASE 1/2 B-AMAZE TRIAL IN
HEMOPHILIA B AT THE 2021 ASH ANNUAL MEETING AND ANNOUNCES  EARLY INITIATION OF
PHASE 1/2 B-LIEVE DOSE-CONFIRMATION TRIAL
    * FREELINE THERAPEUTICS - ANTICIPATES INTERIM DATA READOUT FROM B-LIEVE
TRIAL IN
MIDDLE OF 2022

Source text for Eikon:  ID:nGNX4vqGLz 
Further company coverage:  FRLN.O